Association Between Restless Legs Syndrome and Other Movement Disorders
Several reports describe a possible association between restless legs syndrome and Parkinson disease, as well as Tourette syndrome and restless legs syndrome.
Movement Disorders
Valbenazine and Tetrabenazine Show Promise in Treating Tardive Dyskinesia
Valbenazine and tetrabenazine may represent promising options for the treatment of tardive dyskinesia in patients on long-term antipsychotic medications.
Adjunctive Therapy With Inhaled Levodopa Demonstrates Safety in Parkinson Disease
Combined single inhaled doses of CVT-301 and oral carbidopa/levodopa therapy taken during early morning OFF symptoms demonstrated tolerability and lack of serious adverse events.
Parkinson Disease Risk Increased After Appendectomy
The risk for Parkinson disease is increased after appendectomy.
AAN: Isradipine Offers No Benefit in Parkinson Disease
HealthDay News — Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease (PD), according to a study presented at the annual meeting of the American Academy of Neurology, held from May 4 to 10 in Philadelphia. Tanya Simuni, MD, from the Northwestern University Feinberg School of Medicine in…
Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients With Lewy Body Dementia Examined
Use of zonisamide showed long-term efficacy for Parkinsonism and dementia with Lewy bodies without deterioration of cognitive function.
Carbidopa/Levodopa Enteral Suspension Linked With Improved Quality of Life in Advanced Parkinson’s
Carbidopa/levodopa enteral suspension leads to improvement in quality of like and activities of daily living measures in patients with advanced Parkinson disease.
Trial Supports Further Development of Huntington Antisense Oligonucleotide Therapy
Antisense oligonucleotide drug HTTRx reduced the concentration of mutant huntingtin protein in the cerebrospinal fluid of persons with Huntington disease.
New AAN Guideline: Treating Tourette Syndrome and Other Chronic Tic Disorders
An expert subcommittee of the AAN has released an updated evidence-based clinical practice guideline on treating Tourette syndrome and other chronic tic disorders.
Pimavanserin and Quetiapine Comparable for Psychosis in Parkinson Disease
There were no significant differences between pimavanserin and quetiapine in time to discontinuation, mortality, or improvement in psychosis in patients with Parkinson disease and Lewy body dementia.
Next post in AAN 2019 Conference
